'PA32540 Cuts Gastric Acid Faster Than Enteric-Coated Aspirin' - Medical News Today

'PA32540 Cuts Gastric Acid Faster Than Enteric-Coated Aspirin'
Medical News Today
PA32540 is an investigational coordinated-delivery tablet of immediate-release (IR) omeprazole (40 mg), a proton pump inhibitor (PPI), layered around enteric-coated aspirin (325 mg). The product was developed to provide the cardiovascular benefits of ...
PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ... MarketWatch (press release)

all 7 news articles »

continue reading

Esophageal Reflux Disease Proton Pump Inhibitor Therapy Improves Sleep - Sleep Review

Esophageal Reflux Disease Proton Pump Inhibitor Therapy Improves Sleep
Sleep Review
The use of proton pump inhibitors improves the sleep and daytime quality of life for sufferers of gastroesophageal reflux disease, according to a systematic literature review in the April 2012 issue of Otolaryngology–Head and Neck Surgery.

continue reading

New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics ... - MarketWatch (press release)

New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics ...
MarketWatch (press release)
Gabriela I. Escobar, MD, Northwestern University, and colleagues, presented results of a study (abstractSu1100) of 100 GERD patients who continued to suffer symptoms despite taking proton pump inhibitor (PPI) drugs to inhibit acid reflux.

and more »

continue reading

Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ... - Pain Medicine News

Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ...
Pain Medicine News
... arthritis) trial examined GI risk in adult patients with osteoarthritis or rheumatoid arthritis who were taking celecoxib or diclofenac slow release in combination with the proton pump inhibitor (PPI) omeprazole (Lancet 2010;376:173-179).

continue reading

Clostridium difficile infection: Managing the risks - Journal of the American Academy of Physician Assistants

Clostridium difficile infection: Managing the risks
Journal of the American Academy of Physician Assistants
Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in both the inpatient and outpatient setting. Although most patients experience no adverse effects with these drugs, data are emerging that PPIs are not as benign as ...

continue reading

Antacids linked to higher risk of c. diff, study finds - McKnight's Long Term Care News

Antacids linked to higher risk of c. diff, study finds
McKnight's Long Term Care News
Use of proton pump inhibitors, which have medications used to suppress stomach acid, can increase the risk of Clostridium difficile infections, especially when combined with antibiotics, a new study finds. Investigators analyzed data from 42 ...

continue reading

Many Patients Without Acid Reflux Stay on PPIs - Family Practice News Digital Network

Many Patients Without Acid Reflux Stay on PPIs
Family Practice News Digital Network
Many patients continue to use proton pump inhibitors after pH testing shows that they do not have acid reflux, Dr. Andrew J. Gawron and his colleagues reported in the June issue of Clinical Gastroenterology and Hepatology. In this cross-sectional, ...

continue reading